Yi‐Qun Che

647 total citations
34 papers, 519 citations indexed

About

Yi‐Qun Che is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yi‐Qun Che has authored 34 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Yi‐Qun Che's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Yi‐Qun Che is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Yi‐Qun Che collaborates with scholars based in China, United States and India. Yi‐Qun Che's co-authors include Changzhi Huang, Mei Zhao, Shengkai Huang, Yue Zhang, Di Shen, Jialing Zhong, Hua Peng, Jia Wang, Yuyu Gu and Mei Yang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yi‐Qun Che

34 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Qun Che China 13 311 281 125 62 61 34 519
Claudia Augello Italy 13 368 1.2× 196 0.7× 83 0.7× 49 0.8× 33 0.5× 23 570
Haitham Arabi United States 12 135 0.4× 142 0.5× 67 0.5× 62 1.0× 32 0.5× 29 450
Luísa Matos do Canto Brazil 15 286 0.9× 187 0.7× 214 1.7× 58 0.9× 41 0.7× 34 521
Mitsuru Yoshimoto Japan 10 138 0.4× 141 0.5× 179 1.4× 69 1.1× 37 0.6× 37 436
Jia Bi China 12 359 1.2× 267 1.0× 139 1.1× 24 0.4× 109 1.8× 17 532
Yonggang Shi China 13 282 0.9× 254 0.9× 205 1.6× 57 0.9× 80 1.3× 26 534
Mogens K. Boisen Denmark 13 151 0.5× 154 0.5× 261 2.1× 89 1.4× 41 0.7× 23 443
Pritesh Trivedi United Kingdom 11 139 0.4× 88 0.3× 189 1.5× 39 0.6× 97 1.6× 20 402
Jolanta Szelachowska Poland 12 208 0.7× 113 0.4× 247 2.0× 60 1.0× 117 1.9× 34 508
H. Tsuda Japan 9 343 1.1× 103 0.4× 180 1.4× 39 0.6× 21 0.3× 15 554

Countries citing papers authored by Yi‐Qun Che

Since Specialization
Citations

This map shows the geographic impact of Yi‐Qun Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Qun Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Qun Che more than expected).

Fields of papers citing papers by Yi‐Qun Che

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Qun Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Qun Che. The network helps show where Yi‐Qun Che may publish in the future.

Co-authorship network of co-authors of Yi‐Qun Che

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Qun Che. A scholar is included among the top collaborators of Yi‐Qun Che based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Qun Che. Yi‐Qun Che is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yue, et al.. (2023). IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL. Journal of Oncology. 2023. 1–7. 1 indexed citations
2.
Sun, Xujie, Jinyao Zhang, Li Liu, et al.. (2022). Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC). Translational Oncology. 25. 101538–101538. 3 indexed citations
3.
Luo, Yang, et al.. (2021). Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women. Frontiers in Endocrinology. 12. 766463–766463. 5 indexed citations
4.
Qiao, Liyan, et al.. (2021). CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance. Pharmacogenomics and Personalized Medicine. Volume 14. 591–599. 7 indexed citations
5.
Che, Yi‐Qun, et al.. (2021). Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring. SHILAP Revista de lepidopterología. Volume 8. 1241–1252. 12 indexed citations
6.
Wang, Di, Yue Zhang, & Yi‐Qun Che. (2020). CCND2 mRNA Expression Is Correlated With R-CHOP Treatment Efficacy and Prognosis in Patients With ABC-DLBCL. Frontiers in Oncology. 10. 1180–1180. 12 indexed citations
7.
Che, Yi‐Qun, Di Wang, Peng Liu, et al.. (2020). Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma. Translational Cancer Research. 9(8). 4534–4541. 1 indexed citations
9.
Che, Yi‐Qun, et al.. (2020). <p>Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab</p>. Cancer Management and Research. Volume 12. 8527–8534. 5 indexed citations
10.
Zhang, Yue, Di Wang, Di Shen, Yang Luo, & Yi‐Qun Che. (2020). Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing. PeerJ. 8. e9021–e9021. 16 indexed citations
11.
Luo, Yang, et al.. (2020). <p>Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study</p>. Cancer Management and Research. Volume 12. 5323–5330. 5 indexed citations
12.
Kang, Jingjing, et al.. (2019). Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease Markers. 2019. 1–10. 6 indexed citations
13.
Che, Yi‐Qun, et al.. (2019). <p>Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab</p>. Drug Design Development and Therapy. Volume 13. 3727–3734. 11 indexed citations
14.
Li, Yan, Dongdong Li, Mei Zhao, et al.. (2018). Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells. Life Sciences. 208. 295–304. 55 indexed citations
16.
Che, Yi‐Qun, Yang Luo, Di Wang, Di Shen, & Lin Yang. (2018). [Clinical Analysis of Small Cell Lung Cancer with Bone Marrow Metastases].. SHILAP Revista de lepidopterología. 21(5). 403–407. 1 indexed citations
17.
Huang, Shengkai, Jia Wang, Jia Li, et al.. (2016). Serum microRNA expression profile as a diagnostic panel for gastric cancer. Japanese Journal of Clinical Oncology. 46(9). 811–818. 23 indexed citations
18.
Che, Yi‐Qun, et al.. (2014). Hepatoid adenocarcinoma of the lung: Presenting mediastinal metastasis without transfer to the liver. Oncology Letters. 8(1). 105–110. 26 indexed citations
19.
Wang, Jia, Shengkai Huang, Mei Zhao, et al.. (2014). Identification of a Circulating MicroRNA Signature for Colorectal Cancer Detection. PLoS ONE. 9(4). e87451–e87451. 145 indexed citations
20.
Che, Yi‐Qun, et al.. (2014). Identification of immature granulocytes in cancer chemotherapy patients by cell counting vs. microscopic examination of blood smears. Molecular and Clinical Oncology. 2(2). 207–211. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026